JBS Earnings: Record $86B Revenue, Q4 Profit Flat

(MENAFN- The Rio Times) 3 Key Points -JBS (JBSS3) posted Q4 2025 net income of $415 million, essentially flat year-over-year (+0.5%) and slightly below the $428 million analyst consensus, as record quarterly revenue of $23.06 billion (+15.5%) was offset by a 7% decline in adjusted EBITDA to $1.72 billion - with the EBITDA margin compressing 1.8 percentage points to 7.4%, driven primarily by the US cattle cycle squeezing North American beef margins. -Full-year 2025 delivered record revenue of $86.2 billion (+12%), net income of $2 billion (+13%), and adjusted EBITDA of $6.8 billion with a 7.9% margin - powered by Pilgrim's Pride (15.2% EBITDA margin), Seara (16.9%, with record exports), and JBS Australia (11.3%), while JBS Beef North America posted record $28 billion in revenue but faced historically high cattle costs from the smallest US herd in 75 years. -JBS approved a $1 per share dividend (payable June 17, 2026), reported a 25% ROE (+3.2pp year-over-year) and EPS of $1.89 (+15%), and highlighted a debt structure with no material maturities until 2031 and coupons below US Treasury rates - underpinning CEO Tomazoni's characterization of the results as demonstrating "the strength and resilience of our diversified platform." JBS Q4 2025 Earnings: What Happened 01What Happened

JBS S.A. (JBSS3) is the world's largest meatpacker and a global multi-protein platform, operating across beef, poultry, pork, and prepared foods through six major business units: JBS Beef North America, JBS USA Pork, Pilgrim's Pride (US/Europe/Mexico poultry), Seara (Brazil poultry and prepared foods), JBS Brasil (Friboi beef), and JBS Australia (multi-protein). Headquartered in São Paulo and incorporated in the US (Greeley, Colorado) following its dual-listing process, JBS employs over 270,000 people across operations in more than 20 countries. The company reports in US dollars. JBS earnings for Q4 2025 are covered by The Rio Times as part of its Latin American financial news reporting on B3-listed agribusiness companies.

The quarter encapsulates the central tension in JBS's investment thesis: the global multi-protein platform delivers resilient revenue growth through geographic and protein diversification, but the US cattle cycle - with the smallest herd in 75 years driving livestock costs to historic highs - is compressing the margin of its single largest division. Q4 revenue of $23.06 billion beat analyst expectations by 3%, while EBITDA of $1.72 billion beat the $1.56 billion consensus by 10%, suggesting the market had already priced in the cattle headwinds and was positively surprised by the strength of non-beef segments.

JBS common shares (JBSS3) trade on B3, with BDRs (JBSS32) available for US-exchange exposure. The stock has been one of B3's strong performers, driven by the multi-year improvement in operational execution and the strategic benefit of global diversification. The $1 per share dividend, payable June 17 to shareholders of record on May 18, represents a continuation of the company's capital return policy and reflects confidence in cash generation capacity despite the US cattle headwinds.

Key Drivers Behind JBS's Q4 2025 Results 02Key Drivers US Cattle Cycle and Beef North America Margin Compression US Cattle Cycle and Beef North America Margin Compression

JBS Beef North America - the company's largest unit by revenue - posted record full-year sales of $28 billion but faced severe margin pressure from the US cattle cycle, where the smallest herd in 75 years has driven livestock input costs to historic levels. CEO Tomazoni confirmed that supply conditions are unlikely to improve meaningfully during 2026, as herd rebuilding takes years. Despite this, JPMorgan noted that the division demonstrated "resilience" by exceeding expectations through strong consumer demand and disciplined cost management - suggesting the margin floor may be higher than feared even in the trough of the cattle cycle.

Poultry and Pork as Profitability Engines Poultry and Pork as Profitability Engines

The diversification thesis delivered exactly as designed. Pilgrim's Pride achieved a 15.2% EBITDA margin for the full year - supported by strong US chicken demand, branded growth (Just Bare surpassed $1 billion in sales), and plant optimization in Europe and Mexico. Seara delivered a 16.9% EBITDA margin with the highest export volumes in its history, despite temporary restrictions in China and Europe from avian influenza protocols. JBS USA Pork benefited from consumers trading down from record-priced beef to pork, driving higher volumes. Together, these three segments more than offset the Beef North America margin compression and demonstrate why JBS's multi-protein model generates more stable consolidated returns than pure-play beef processors.

JBS Australia and Brazil Beef JBS Australia and Brazil Beef

JBS Australia reported an 11.3% EBITDA margin, benefiting from favorable cattle cycle dynamics in Australia (in contrast to the US), higher volumes in both domestic and export markets, and growing US-bound beef exports that capture premium pricing. JBS Brasil (Friboi) posted a 6.2% EBITDA margin with record processing volumes, supported by strong demand, brand strength, and the continued growth of value-added products through the Friboi+ platform. Brazil's cattle cycle is in a favorable phase with ample supply, providing a natural hedge against the US cattle headwinds - a key advantage of JBS's dual-hemisphere beef operations.

JBS Q4 2025 Financial Detail 03Financial Detail

The Q4 revenue-profit divergence is the key financial story. Revenue grew 15.5% to a record $23.06 billion, but EBITDA declined 7% to $1.72 billion and net income was essentially flat at $415 million. This means JBS processed and sold significantly more protein at lower margins - a pattern consistent with the US cattle cycle dynamics where higher input costs are partially passed through to consumers but compress processor margins. The EBITDA margin of 7.4% (-1.8pp) was still above the mid-cycle average for a diversified protein company, and the beat versus the $1.56 billion consensus suggests the margin compression was less severe than feared.

Full-year capital returns reflect the strong cash generation profile. The 25% ROE and $1.89 EPS (+15%) demonstrate that JBS is extracting more value per dollar of equity despite the mixed margin environment. The $1 per share dividend signals management's confidence in sustaining payouts even as the cattle cycle persists. Leverage of 2.39x - up from 1.9x in 2024 but stable versus Q3 2025 - remains within the company's long-term target range and is supported by a debt maturity profile with no material payments until 2031.

The debt structure is a strategic asset. JBS highlighted that its bond coupons through 2032 are priced below US Treasury rates - an extraordinary distinction for a Brazilian-origin company that reflects the market's confidence in JBS's creditworthiness and the diversification benefit of operating across multiple currencies, geographies, and protein cycles. This low-cost, long-dated debt effectively subsidizes the company's ability to invest through the cattle cycle downturn without balance sheet stress.

Management Signals from JBS Management Signals

CEO Tomazoni's emphasis on "the strength and resilience of our diversified platform across proteins and geographies" is more than corporate boilerplate in this context - it directly addresses the central investor concern that US cattle costs would overwhelm the consolidated P&L. The fact that JBS delivered 15% revenue growth and 13% net income growth in a year when its largest single division faced the worst cattle supply conditions in three-quarters of a century validates the multi-protein strategy at exactly the moment it was being tested.

Tomazoni told Reuters that US cattle supply conditions are "unlikely to improve significantly" in 2026, setting expectations for continued Beef North America margin pressure. However, the implication is that the other five business units - which collectively delivered strong margins and growth - will continue to compensate. This is a management team that has learned to generate consistent earnings through the cycle rather than depending on any single segment for profitability.

The dividend of $1 per share and the no-maturities-until-2031 debt profile together signal that JBS views its capital position as secure enough to return cash to shareholders while maintaining investment flexibility. The sub-Treasury coupon rates on its bonds are a competitive moat in the current high-rate environment - JBS's cost of debt is lower than the risk-free rate, meaning the company benefits from investing at returns above its financing cost across all geographies.

What to Watch Next for JBS 04Watch Next

US cattle herd rebuilding timeline sets the cadence for margin recovery. The current cycle - with the smallest herd since the late 1940s - typically takes 3–5 years to reverse as ranchers retain heifers for breeding rather than slaughter, gradually expanding supply. Until cattle availability improves, Beef North America's margins will remain structurally below historical averages. Any signs of accelerated herd retention in USDA Cattle on Feed reports would be an early indicator of the turn.

Trade policy and the Strait of Hormuz situation are relevant to JBS's export flows. The Middle East absorbs over 30% of Brazilian poultry exports, with roughly half transiting the Hormuz chokepoint. Any prolonged disruption would affect Seara's export margins and routing, though JBS's geographic diversification (US, Europe, Australia) provides redirect options unavailable to smaller Brazilian protein exporters. Additionally, any escalation of US-China trade tensions could impact Pilgrim's export volumes to Asia.

Seara's China and Europe market access normalization is a near-term catalyst. Avian influenza-related restrictions temporarily limited Seara's access to key markets in 2025, yet the unit still posted record export volumes. Full normalization of these trade flows would provide incremental volume and potentially margin uplift, as China and the EU are premium-pricing destinations for processed poultry products.

JBS Quarterly Results (Q4 2025 vs Q4 2024)

Metric	Q4 2024	Q4 2025	Chg
Net Revenue	$19.97 bn	$23.06 bn (record)	+15.5%
Adj. EBITDA	$1.85 bn	$1.72 bn	-7.0%
Adj. EBITDA Margin	9.2%	7.4%	-1.8pp
Net Income	$413 mn	$415 mn	+0.5%

JBS Annual and Segment Summary (FY2025)

Metric	Value
FY Net Revenue (Record)	$86.2 bn (+12%)
FY Net Income	$2.0 bn (+13%)
FY Adj. EBITDA	$6.8 bn | 7.9% margin
EPS | ROE	$1.89 (+15%) | 25% (+3.2pp)
Leverage (ND/EBITDA)	2.39x (2024: 1.9x)
Pilgrim's Pride Margin	15.2% EBITDA
Seara Margin	16.9% EBITDA (record exports)
JBS Australia Margin	11.3% EBITDA
JBS Brasil (Friboi) Margin	6.2% EBITDA (record volume)
Beef NA Revenue	$28 bn (record; margin pressured)
Dividend	$1.00/share | Pay: Jun 17, 2026

Risks Facing JBS 05Risks

The US cattle cycle may persist longer than expected. With the smallest herd in 75 years, the rebuilding process is inherently multi-year, and drought conditions in key cattle-producing states could delay recovery further. If Beef North America margins remain compressed through 2027–2028, the division - which generates roughly a third of consolidated revenue - would continue as a drag on consolidated profitability, requiring the other five units to over-deliver to maintain earnings growth.

Animal health and trade disruptions are permanent risks for a global protein company. Avian influenza already restricted Seara's access to China and Europe in 2025, and any recurrence - or a new outbreak of African swine fever, BSE, or foot-and-mouth disease - could trigger immediate market closures that disrupt export flows across multiple segments simultaneously. JBS's geographic diversification provides resilience but not immunity: a multi-country disease event could affect several business units at once.

Leverage has risen from 1.9x to 2.39x, and while management describes this as "in line with long-term targets," it is notably higher than the sub-2x levels the company had recently achieved. In a rising rate environment - US interest rates remain elevated even as Brazil's Selic begins to decline - the absolute cost of servicing this debt increases. JBS's below-Treasury coupon rates mitigate this risk, but any downgrade to the company's credit rating (currently BBB-/Baa3 at the investment-grade threshold) could widen spreads and increase refinancing costs when the current debt eventually matures.

Global Protein Sector Context Sector Context

The global protein industry is navigating a complex matrix of divergent cattle cycles, trade disruptions, and shifting consumer demand patterns. In the US, the beef sector is in its deepest supply trough since World War II - the USDA estimates the total cattle inventory at approximately 87 million head, versus over 100 million at cycle peaks - which supports retail beef prices near record levels but compresses processor margins. By contrast, Brazil and Australia are in favorable phases of their cattle cycles with ample supply, creating a geographic arbitrage that benefits companies with dual-hemisphere operations.

Poultry has emerged as the global protein of choice, with per-capita consumption growing faster than beef or pork in every major market. Record US beef prices are driving consumers toward chicken and pork substitution, directly benefiting JBS 's Pilgrim's Pride and JBS USA Pork divisions. Globally, chicken trade flows are being reshaped by avian influenza outbreaks that periodically close key import markets - creating both risk and opportunity for companies with diversified production bases that can redirect supply to unaffected destinations.

JBS's $86 billion revenue scale makes it the undisputed global leader, approximately 2x the size of its nearest competitor (Tyson Foods at ~$53 billion). This scale advantage manifests in purchasing power with livestock suppliers, logistics efficiency, and the ability to absorb regional shocks across a portfolio that spans five proteins and more than 20 countries. The ongoing Middle East tensions and potential Strait of Hormuz disruption add an additional layer of complexity for Brazilian protein exporters - over 30% of Brazilian poultry exports transit this route - but JBS's ability to redirect volumes through alternative channels and geographies provides a buffer that smaller, single-market competitors lack.

JBS earnings | JBSS3 Q4 2025 results | global meatpacker protein company | Brazil agribusiness | Latin American financial news | The Rio Times

MENAFN26032026007421016031ID1110909521